Association of Survival and Progression-Free Survival with Immune Response in HLA-A2+ Newly- Diagnosed GBM Patients in Randomized Double-Blind Placebo-Controlled Phase 2 Trial of Dentritic Cell (DC) Immunotherapy with ICT-107

Event Name/Location

The 20th Annual Scientific Meeting and Education Day for the Society for Neuro-Oncology; 2015 November 19-22; San Antonio, TX

Presentation Date

11-2015

Document Type

Conference Presentation

Presenters / Authors

Patrick Wen
David Reardon
Surasak Phuphanich
Robert Aiken
Joseph Landolfi
William Curry
Jay-Jiguang Zhu
Michael Glantz
David Peereboom
James Markert
Renato Larocca
Donald O'Rourke
Karen Fink
Lyndon Kim
Michael Gruber
Glenn Lesser
Ed Pan
Radleigh Santos, Torrey Pines Institute for Molecular StudiesFollow
Clemencia Pinilla, Torrey Pines Institute for Molecular Studies
John Yu

NSUWorks Citation

Wen, Patrick; Reardon, David; Phuphanich, Surasak; Aiken, Robert; Landolfi, Joseph; Curry, William; Zhu, Jay-Jiguang; Glantz, Michael; Peereboom, David; Markert, James; Larocca, Renato; O'Rourke, Donald; Fink, Karen; Kim, Lyndon; Gruber, Michael; Lesser, Glenn; Pan, Ed; Santos, Radleigh; Pinilla, Clemencia; and Yu, John, "Association of Survival and Progression-Free Survival with Immune Response in HLA-A2+ Newly- Diagnosed GBM Patients in Randomized Double-Blind Placebo-Controlled Phase 2 Trial of Dentritic Cell (DC) Immunotherapy with ICT-107" (2015). Mathematics Faculty Proceedings, Presentations, Speeches, Lectures. 375.
https://nsuworks.nova.edu/cnso_math_facpres/375